Mentari Therapeutics, Inc. (MTRI)
12.22
-3.78
(-23.62%)
USD |
NASDAQ |
Nov 10, 16:00
12.80
+0.58
(+4.75%)
After-Hours: 16:16
Mentari Therapeutics Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 29, 2026 | 68.29 |
| September 28, 2026 | 67.55 |
| September 25, 2026 | 68.54 |
| September 24, 2026 | 69.54 |
| September 23, 2026 | 68.54 |
| September 22, 2026 | 69.04 |
| September 21, 2026 | 68.54 |
| September 18, 2026 | 67.55 |
| September 17, 2026 | 69.04 |
| September 16, 2026 | 63.58 |
| September 15, 2026 | 63.58 |
| September 14, 2026 | 64.57 |
| September 11, 2026 | 64.07 |
| September 10, 2026 | 65.07 |
| September 09, 2026 | 65.07 |
| September 08, 2026 | 66.06 |
| September 04, 2026 | 68.54 |
| September 03, 2026 | 66.06 |
| September 02, 2026 | 67.05 |
| September 01, 2026 | 65.56 |
| August 31, 2026 | 67.05 |
| August 28, 2026 | 68.54 |
| August 27, 2026 | 71.03 |
| August 26, 2026 | 71.03 |
| August 25, 2026 | 71.52 |
| Date | Value |
|---|---|
| August 24, 2026 | 71.03 |
| August 21, 2026 | 72.52 |
| August 20, 2026 | 78.48 |
| August 19, 2026 | 78.97 |
| August 18, 2026 | 71.52 |
| August 17, 2026 | 72.52 |
| August 14, 2026 | 73.01 |
| August 13, 2026 | 71.03 |
| August 12, 2026 | 71.52 |
| August 11, 2026 | 72.52 |
| August 10, 2026 | 70.03 |
| August 07, 2026 | 73.01 |
| August 06, 2026 | 71.03 |
| August 05, 2026 | 69.54 |
| August 04, 2026 | 74.01 |
| August 03, 2026 | 72.52 |
| July 31, 2026 | 73.01 |
| July 30, 2026 | 74.50 |
| July 29, 2026 | 82.95 |
| July 28, 2026 | 82.95 |
| July 27, 2026 | 81.46 |
| July 24, 2026 | 84.93 |
| July 23, 2026 | 91.89 |
| July 22, 2026 | 82.45 |
| July 21, 2026 | 76.49 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| NervGen Pharma Corp. | 4.319 |
| Milestone Pharmaceuticals, Inc. | 4.689 |
| Appili Therapeutics, Inc. | -- |
| Clearmind Medicine, Inc. | 0.1058 |
| Lexaria Bioscience Corp. | 1.639 |
Price to Book Value Related Metrics
| PS Ratio | 66.47 |
| Price | 12.22 |
| Earnings Yield | -25.41% |
| Market Cap | 67.13M |